Stat3 inhibits WTX expression through up-regulation of microRNA-370 in Wilms tumor

Xu Cao1, Dehong Liu, Xiangming Yan

  • 1Department of Surgery, Childrens' Hospital Affiliated to Soochow University, Soochow University, Suzhou 215003, PR China.

FEBS Letters
|January 22, 2013
PubMed

Insights

Signal transducer and activator of transcription 3 (Stat3) is highly activated in Wilms tumor. Stat3 promotes Wilms tumor cell proliferation by up-regulating microRNA-370, which inhibits WTX expression.

Area of Science:

  • Pediatric oncology
  • Molecular biology
  • Cancer genetics

Background:

  • Wilms tumor (WT) is a heterogeneous childhood kidney cancer with identified genetic mutations.
  • The molecular mechanisms driving WT tumorigenesis are not fully understood.
  • Signal transducer and activator of transcription 3 (Stat3) is a key transcription factor implicated in oncogenesis.

Purpose of the Study:

  • To investigate the role of Stat3 activation in Wilms tumor development.
  • To elucidate the molecular mechanisms by which Stat3 influences Wilms tumor progression.
  • To identify potential therapeutic targets within the Stat3 signaling pathway.

Main Methods:

  • Comparative analysis of Stat3 activation in Wilms tumor tissues versus adjacent tissues.
  • In vitro studies using G401 cells treated with IL-6 or transfected with activated Stat3.
  • Molecular analysis to determine the effect of Stat3 on WTX expression and microRNA-370 levels.

Main Results:

  • Stat3 was found to be highly activated in Wilms tumor tissues.
  • IL-6 treatment and activated Stat3 transfection promoted proliferation in G401 cells.
  • Stat3 was shown to inhibit WTX expression via up-regulation of microRNA-370.

Conclusions:

  • The Stat3/microRNA-370/WTX regulatory axis is a critical mechanism in Wilms tumor pathogenesis.
  • Targeting Stat3 activation may offer a therapeutic strategy for Wilms tumor.
  • Further research into this pathway could reveal novel insights into childhood kidney cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...